Clinical Trial Update: Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating teclistamab in combination therapy in elderly patients with multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: University Hospital, Lille | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING